Skip to main content
. 2011 Jun 1;52(11):1324–1331. doi: 10.1093/cid/cir203

Table 1.

Baseline Characteristics of Children Who Received Antibiotics for Ventilator-Associated Tracheitis (VAT)

118 patients meeting VAT criteriaa
150 patients with clinician-suspected VATb
Variable ≤6 days of antibiotics (n = 36) ≥7 days of antibiotics (n = 82) P ≤6 days of antibiotics (n = 50) ≥7 days of antibiotics (n = 100) P
Age, median years (IQR) 1.0 (0.9–12) 0.9 (0.6–14) 0.8 (0.5–12) 0.8 (0.5–14)
PRISMc score, median value (IQR) 12 (8–20) 12 (8–21) .60 12 (9–20) 12 (10–26)
Unit .24 .56
NICU 28 (78) 55 (67) 18 (36) 41 (41)
PICU 8 (22) 27 (33) 32 (64) 59 (59)
Male sex 24 (67) 54 (66) .93 35 (70) 63 (63) .40
Gram-negative organisms from sputum 26 (72) 68 (83) .18 30 (60) 78 (78) .02
Preexisting conditions .22 .47
Prematurity 6 (17) 22 (27) 15 (30) 33 (33)
Neuromuscular 9 (25) 10 (12) 9 (18) 10 (10)
Cardiovascular 3 (8) 13 (16) 5 (10) 16 (16)
Genetic/metabolic 2 (6) 4 (5) 2 (4) 6 (6)
Respiratory 3 (8) 12 (15) 3 (6) 13 (13)
Trauma 7 (20) 10 (12) 8 (16) 10 (10)
Gastrointestinal 4 (11) 2 (2) 4 (8) 2 (2)
Immunocompromised 0 (0) 1 (1) 0 (0) 2 (2)

NOTE. Data are numbers (%) of patients, unless otherwise indicated. IQR, interquartile range; NICU, neonatal intensive care unit; PICU, pediatric intensive care unit.

a

Based on previously published definition of VAT [10–12, 14].

b

Children receiving antibiotic courses for clinician-suspected VAT (inclusive of the 118 patients who met criteria for VAT).

c

Pediatric risk of mortality score from time of VAT diagnosis.